Department of Pediatric Endocrinology, Namazi Hospital, Shiraz University of Medical Sciences, Shiraz, Iran.
J Bone Miner Res. 2013 Jun;28(6):1501-8. doi: 10.1002/jbmr.1868.
Juvenile Paget's disease (JPD) is a rare heritable osteopathy characterized biochemically by markedly increased serum alkaline phosphatase (ALP) activity emanating from generalized acceleration of skeletal turnover. Affected infants and children typically suffer bone pain and fractures and deformities, become deaf, and have macrocranium. Some who survive to young adult life develop blindness from retinopathy engendered by vascular microcalcification. Most cases of JPD are caused by osteoprotegerin (OPG) deficiency due to homozygous loss-of-function mutations within the TNFRSF11B gene that encodes OPG. We report a 3-year-old Iranian girl with JPD and craniosynostosis who had vitamin D deficiency in infancy. She presented with fractures during the first year-of-life followed by bone deformities, delayed development, failure-to-thrive, and pneumonias. At 1 year-of-age, biochemical studies of serum revealed marked hyperphosphatasemia together with low-normal calcium and low inorganic phosphate and 25-hydroxyvitamin D levels. Several family members in previous generations of this consanguineous kindred may also have had JPD and vitamin D deficiency. Mutation analysis showed homozygosity for a unique missense change (c.130T>C, p.Cys44Arg) in TNFRSF11B that would compromise the cysteine-rich domain of OPG that binds receptor activator of NF-κB ligand (RANKL). Both parents were heterozygous for this mutation. The patient's serum OPG level was extremely low and RANKL level markedly elevated. She responded well to rapid oral vitamin D repletion followed by pamidronate treatment given intravenously. Our patient is the first Iranian reported with JPD. Her novel mutation in TNFRSF11B plus vitamin D deficiency in infancy was associated with severe JPD uniquely complicated by craniosynostosis. Pamidronate treatment with vitamin D sufficiency can be effective therapy for the skeletal disease caused by the OPG deficiency form of JPD.
青少年佩吉特病(JPD)是一种罕见的遗传性骨病,其生化特征为血清碱性磷酸酶(ALP)活性显著升高,源于骨骼周转率的普遍加速。受影响的婴儿和儿童通常会遭受骨痛和骨折、畸形、耳聋和大头症。一些存活到成年的患者会因血管微钙化引起的视网膜病变而失明。大多数 JPD 病例是由骨保护素(OPG)缺乏引起的,这是由于 TNFRSF11B 基因中的纯合功能丧失突变导致 OPG 编码缺失。我们报告了一例伊朗 3 岁女孩患有 JPD 和颅缝早闭,她在婴儿期患有维生素 D 缺乏症。她在生命的第一年出现骨折,随后出现骨骼畸形、发育迟缓、生长不良和肺炎。在 1 岁时,对血清的生化研究显示,磷酸酶显著升高,同时伴有正常钙水平、低无机磷和 25-羟维生素 D 水平。这个近亲家族的前几代人中可能也有 JPD 和维生素 D 缺乏症。突变分析显示 TNFRSF11B 中的纯合错义改变(c.130T>C,p.Cys44Arg)导致 OPG 的富含半胱氨酸结构域受损,该结构域结合核因子 κB 受体激活物配体(RANKL)。父母双方均为该突变的杂合子。患者的血清 OPG 水平极低,RANKL 水平显著升高。她对快速口服维生素 D 补充治疗后静脉注射帕米膦酸二钠治疗反应良好。我们的患者是首例报道的伊朗 JPD 病例。她在 TNFRSF11B 中的新突变加上婴儿期的维生素 D 缺乏症与严重的 JPD 相关,独特地伴有颅缝早闭。充足的维生素 D 和帕米膦酸二钠治疗可有效治疗 OPG 缺乏型 JPD 引起的骨骼疾病。